SCHEMBL2939775

SCHEMBL2939775

NC(c1ccccc1)c1ccc(O)cc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.57
TDO2 P48775 1/20 0.57
DPP4 P27487 2/20 0.48
F2 P00734 1/20 0.48
CA12 O43570 1/20 0.48
CA1 P00915 1/20 0.48
CA2 P00918 1/20 0.48
GLA P06280 1/20 0.48
CA3 P07451 1/20 0.48
CA4 P22748 1/20 0.48
CA9 Q16790 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
CA14 Q9ULX7 1/20 0.48
MMP3 P08254 1/20 0.46
BCL2L1 Q07817 1/20 0.46
ESR1 P03372 2/20 0.44
ESR2 Q92731 2/20 0.44
LMNA P02545 2/20 0.44
ALDH1A1 P00352 1/20 0.44
HSD17B10 Q99714 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL926425 0.89 ESR1 (0.52) IDO1TDO2CA12CA1CA2
SCHEMBL11478580 0.87 DPP4 (0.61) DPP4F2LMNAHIF1ATAAR1
SCHEMBL11480062 0.87 DPP4 (0.61) DPP4F2LMNAHIF1ATAAR1
Aminodiphenylmethane SCHEMBL7841 0.84 DPP4 (0.65) DPP4F2LMNAHIF1ATAAR1
Bromide SCHEMBL10781988 0.83 DPP4 (0.67) IDO1TDO2DPP4F2CA12
Aminodiphenylmethane SCHEMBL7719817 0.81 DPP4 (0.55) DPP4F2LMNAALDH1A1HIF1A
Aminodiphenylmethane SCHEMBL8686295 0.81 DPP4 (0.61) DPP4F2LMNAHIF1ATAAR1
Aminodiphenylmethane SCHEMBL2408346 0.81 DPP4 (0.61) DPP4F2LMNAHIF1ATAAR1
Aminodiphenylmethane SCHEMBL6970159 0.81 DPP4 (0.61) DPP4F2LMNAHIF1ATAAR1
Aminodiphenylmethane SCHEMBL8518249 0.81 DPP4 (0.61) DPP4F2LMNAHIF1ATAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109796743-B Self-capacitance antibacterial modified PET/PC alloy and preparation method thereof 华政炎 2021-06-25 CN claimed
CN-109796743-A Self-capacitance antibacterial modified PET/PC alloy and preparation method thereof 华政炎 2019-05-24 CN claimed
EP-2079711-B1 2-PHENYL-6-AMINOCARBONYL-PYRIMIDINE DERIVATIVES AND THEIR USE AS P2Y12 RECEPTOR ANTAGONISTS ACTELION PHARMACEUTICALS LTD (CH) 2010-01-06 EP claimed
CN-115920973-B Preparation method of full deuterated methanol 泽升科技(广州)有限公司 2023-05-26 CN disclosed
CN-115920973-A Preparation method of deuterated methanol 泽升科技(广州)有限公司 2023-04-07 CN disclosed
CN-109796743-B Self-capacitance antibacterial modified PET/PC alloy and preparation method thereof 华政炎 2021-06-25 CN disclosed
CN-109796743-A Self-capacitance antibacterial modified PET/PC alloy and preparation method thereof 华政炎 2019-05-24 CN disclosed
CN-105085726-B A kind of catalytic component and catalyst for olefinic polymerization 中国石油化工股份有限公司 2017-11-07 CN disclosed
CN-104955802-B catalyst compositions and methods of making and using the same 切弗朗菲利浦化学公司 2017-10-13 CN disclosed
CN-104955802-A Novel catalyst compositions and methods of making and using the same CHEVRON PHILLIPS CHEMICAL CO 2015-09-30 CN disclosed
WO-2010140902-A1 INHIBITORS OF MACROPHAGE MIGRATION INHIBITORY FACTOR HAMPTON MARK (NZ) 2010-12-09 WO disclosed
EP-0725074-A2 Compounds suitable for use as intermediates in the preparation of Androst-3,5-dien-3-carboxy derivatives SANKYO COMPANY LIMITED (JP) 1996-08-07 EP disclosed
US-5536714-A Steroid derivatives for the treatment of prostatic hypertrophy their preparation and uses SANKYO COMPANY, LIMITED (JP) 1996-07-16 US disclosed
EP-0484094-B1 Azasteroid compounds for the treatment of prostatic hypertrophy, their preparation and use SANKYO CO (JP) 1996-06-26 EP disclosed
US-5302621-A Azasteroid compounds for the treatment of prostatic hypertrophy, their preparation and use SANKYO COMPANY, LIMITED (JP) 1994-04-12 US disclosed
EP-0567271-A2 Steroid derivatives for the treatment of prostatic hypertrophy, their preparation and uses SANKYO COMPANY LIMITED (JP) 1993-10-27 EP disclosed
US-5153226-A Administering as anticholesterol agents, for atherosclerosis WARNER-LAMBERT COMPANY (US) 1992-10-06 US disclosed
CN-1062145-A Azasteroid compounds for the treatment of prostatic hypertrophy, their preparation and use SANKYO CO (JP) 1992-06-24 CN disclosed
EP-0484094-A2 Azasteroid compounds for the treatment of prostatic hypertrophy, their preparation and use Sankyo Company Limited (JP) 1992-05-06 EP disclosed
EP-0415413-A1 Acat inhibitors WARNER-LAMBERT COMPANY (US) 1991-03-06 EP disclosed